Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Mol Cancer Res. 2019 Oct 16;18(1):46–56. doi: 10.1158/1541-7786.MCR-19-0359

Figure 6. Expression of VE-cadherin and p21 in Response to MAPK13 and ATRA.

Figure 6.

Western blots for AP-2γ, p38δ, VE-cadherin, p21 and GAPDH showing response in HCC1954 and SKBR3 cells with knockdown of TFAP2C with or without co-knockdown of MAPK13 (top panels). Western blots showing changes of expression of AP-2γ, VE-cadherin, p21 and GAPDH in HCC1954 and SKBR3 with knockdown using NT vs. TFAP2C siRNA with increasing concentration of ATRA at 0, 0.1 and 0.5 μM (bottom panels).